NASDAQ:ASMB
Assembly Biosciences, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.assemblybio.comipo date
Dec 17, 2010
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also developing ABI-H3733 that has complet...Show More
Earnings
Earnings Release in 11 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus